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Abstract 
 
Depression is often seen as a growing public health issue, and this is 
reflected in a growing number of interventions. This paper discusses the 
ethical implications of interventions conducted at the population, as opposed 
to the individual, level. We start by outlining the main ethical considerations of 
such approaches. Particularly we argue that given the stigma associated with 
diagnoses and labels of mental illness, including depression, allocation or 
adoption of such labels greatly effects the lives of sufferers. While long-term 
social and legal efforts may be made to reduce stigma and discrimination, the 
potential consequences of such labels must be recognised and greater 
sensitivity to this must illuminate discussions and practice of diagnosis, 
intervention and treatment. With this in mind, we proceed to consider several 
specific large-scale interventions to address depression. These include: web-
based interventions; over the counter sales of anti-depressants; school-based 
interventions and interventions in the young and environmental interventions. 
We conclude that many types of large-scale intervention are not ethically 
unproblematic and that there is a significant difference between treating 
people who seek help, and searching for people whom we think need help. 
Consequently, in the current climate of prevailing attitudes towards mental 
health generally, and depression in particular, the use of population-level 
interventions raises serious ethical considerations that cannot be ignored. 
     
Keywords 
Depression; Intervention; Ethics; Stigma; Screening; Population-level; Self-
care 
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The ethical context of population-level interventions against depression 
 
Introduction 
 
This paper was originally published in Germany as a chapter in a book titled 
Volkskrankheit Depression? Bestandsaufnahme und Perspektiven (Holm & 
Burgess, 2006). The book was a response to the perceived increase in the 
prevalence of depression. The remit of this chapter, which was part of a 
section on interventions,  was to discuss the ethical context of conducting 
large-scale (population-level) interventions to address depression. Our work 
was written in English and translated into German. This working paper  
reproduces our original English language draft and is published nowhere else 
in English. A few alterations have been made but these are mainly 
grammatical and contextual rather than substantive. 
 
Depression is a major public health problem. On any kind of burden of 
disease measurement depression appears as one of the main courses of ill 
health and loss of earnings across the life cycle. In discussions about ethics in 
psychiatry there has been a tendency to focus on the ethical problems raised 
by the treatment of individuals, for example issues concerning compulsory 
detention and treatment (Bloch et al, 1999; Hirsch and Harris, 1998). In this 
chapter we will leave aside these traditional concerns of the ethics of 
psychiatry and instead look at some of the ethical issues that are raised when 
we try to tackle depression at the population level through large-scale 
interventions. In this area many parallels can be drawn to ongoing discussions 
in public health ethics (e.g. to general discussions about screening) but there 
are areas where public health interventions targeting mental illness differ from 
the standard public health interventions targeting physical diseases. The 
interventions that we will discuss in this chapter fall into two categories: 
 
1. Untargeted primary prevention, e.g. changes to the built environment 
aimed at reducing the incidence of depression 
2. Targeted primary or secondary prevention, e.g. interventions aimed 
at people who during screening have been found to have increased 
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risk of developing depression, or have sub-clinical depression. This can 
either rely on mass screening, on professional screening, or on self-
identification possibly aided by easy access to screening tools on the 
internet. 
 
In this chapter we will give a brief overview of the main ethical issues and then 
proceed to discuss stigma and screening, followed by an examination of some 
intervention strategies including some aimed at adult populations; school-
based interventions and interventions aimed at children or adolescents, and a 
brief discussion of environmental interventions. 
 
An overview of the main ethical issues 
 
What are the main ethical issues that mass interventions for depression 
raise? There are at least five that will recur in our discussion: 
 
1. Is there evidence that the intervention strategy works? It is ethically 
problematic to waste resources on interventions that do not work? 
2. Are there negative consequences for those labelled as “at risk” for 
depression? 
3. How reliable are the methods used for labelling persons as “at risk”? 
4. Are there any elements of coercion or paternalism involved in the 
intervention strategy? 
5. Will the intervention promote justice in health or health care? 
 
The first three of these ethical considerations are discussed in more detail 
later, but here we will briefly discuss the two last issues. 
 
Respect for self determination is a central concern of medical ethics; and for 
any  public health intervention that involves coercion or some form of 
paternalism we need to look carefully at whether it is justified to breach 
peoples right to self determination. In the current context direct coercion is not 
the concern, no one will presumably be forced to take a screening test for 
depression as part of a public health intervention, but if screening takes place 
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in institutions like schools there may be a significant element of informal 
coercion (e.g. “everyone else in the class participates, so why won’t you?!”). 
 
In the health promotion context paternalism is often what we could call 
informational paternalism. We, the public health professionals, only include 
part of the truth in our health promotion messages either because we believe 
that people cannot process complex information, or because telling people the 
whole truth would make the message much less convincing. An example of 
such misguided informational paternalism was the, now fortunately no longer 
used slogan “Cancer that is discovered in time can be cured”. This is either 
tautological (i.e. the definition of a “cancer that is discovered in time” is that it 
can be cured), or false. 
 
The justice consideration arises because we know that unless public health 
interventions are very carefully designed there will often be differential uptake 
in different social groups, and that it is often the well educated who will benefit 
the most. This means that a public health intervention may benefit the public 
health, while at the same time enlarging the differences in health status 
between different social groups. This is clearly a non-desirable outcome, 
especially if the intervention is paid for by public money. 
 
A final introductory consideration that is important for the ethical evaluation of 
different intervention strategies is “Qui bono?”. Who benefits from the recent 
growth in the estimates of the number of persons in the population suffering 
from depression? Many commentators have remarked on the temporal co-
incidence of the growth in the estimates and the introduction of the Selective 
Serotonin Reuptake Inhibitor (SSRI) class of anti-depressants and suggested 
that it is the pharmaceutical industry that, with the collusion of psychiatrists, 
have been influencing the way depression is conceptualised, thereby 
influencing the number of people classified as depressed.  
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Stigma and screening 
 
In psychiatric disease, we can see a contemporary expression of the mind-
body dualism that has long preoccupied Western culture. Fear and paranoia 
surrounding non-corporeal disease mean that to anyone suffering from any 
psychiatric disorder and being labelled as such, will be attached certain 
stigma. While the problem of stigmatising mental illness is well documented 
(Crisp et al, 2000), mental health literacy among the public is still poor (Jorm, 
2000). Consequently, someone labelled as having a psychiatric disease may 
find that this label dominates their life as much as the disorder itself. The 
stigma attached to the label becomes a window through which the sufferer 
may view themselves, and through which the wider world will view the 
sufferer. While public prejudices and stereotypes will vary between particular 
diseases (Crisp et al, 2000), generally these can lead to social inequality for 
sufferers, for example by limiting their access to employment and insurance. 
This has been echoed by Benedetto Saraceno, as the director of  the World 
Health Organization’s Department of Mental Health and Substance Abuse: 
 
“Mental disorders are inextricably linked to human rights issues. 
The stigma, discrimination and human rights violations that 
individuals and families affected by mental disorders suffer are 
intense and pervasive.”       
               (WHO, 2004:3) 
 
Although not suffering a mood disorder like depression, Gordon’s description 
of her own personality disorder highlights one fear of being labelled as 
mentally ill: 
 
“I fear that now I have been given this label I will be seen by all 
subsequent professionals in the light of my label without being 
given the chance for the real me to show through.”   
        (Gordon, 1994:420) 
 
Working Paper no.5, CISHE, School of Social Sciences, Cardiff University 
May 2006 7
The fear of being forever labelled, and always being subjected to the stigma 
attached to that label, is key to why a person with symptoms of psychiatric 
disease (assuming they are even aware of what their symptoms mean, or that 
they are treatable) may be reluctant to present this to a GP (Halter, 2004). 
Being labelled as suffering from depression is no different, despite the fact 
that it is a one of the most prevalent forms of psychiatric disorder (Halter, 
2004; WHO 2004). Indeed, the stigma attached to depression is possibly 
complicated by the fact that the word has a lay usage as well as a clinical one. 
As a result, depression is often seen as synonymous with merely being sad. 
Clearly, there is an urgent ethical need to address the stigma attached to 
depression in order to remove the social inequality experienced by sufferers. 
Education is often seen as key to achieving this (Paykel & Priest, 1992), with 
interventions to address public perceptions of depression taking a central role. 
In the UK, for example, the Royal College of Psychiatrists and the Royal 
College of General Practitioners undertook a 5 year project (1992-1996) 
called the Defeat Depression Campaign one of the aims of which was to 
reduce the stigma associated with depression (Royal College of Psychiatrists, 
2005). While evaluation of the scheme suggested that it had a positive affect 
on public attitudes towards depression, these effects were small and could not 
be conclusively attributed to the campaign (Paykel et al, 1998).  
 
However, in dealing with the stigma of depression, it is important to note that 
health education interventions are slow to produce effects (Crisp et al, 2000). 
In addition, while such interventions may seek to reduce stigma around 
depression by increasing public understanding of it, it has been suggested 
that stigmatising opinions do not necessarily result from a lack of 
understanding of mental disorders (Crisp et al, 2000). To particularise Crisp et 
al’s generalised conclusions to depression, stigmatising opinions are hard to 
change, consequently strategies must directly address discrimination towards 
people with depression (e.g. in the work place, (Glozier, 1998)), alongside 
increasing public understandings of depression, in order to reduce the social 
injustice experienced by the depressed. A part of this must be attention to 
representations of depression in the media (Crisp et al, 2000), where indirect 
cultural messages reinforce more directed, public health ones. Complex 
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interventions which reduce the stigma associated with depression and actively 
address discrimination through legal and social action, are clearly necessary 
to improve social justice for sufferers and to encourage those who do suffer to 
seek treatment. However, these are long-term strategies and in the meantime 
the stigma of depression continues to have a profound and complex impact 
on the lives of those who suffer from it. Consequently, those involved in 
diagnosis must be sensitive to the social consequences of the label that their 
diagnosis imparts, as well as the clinical ones.  
 
It is documented that once sufferers do present with symptoms, despite the 
fact that several different tools exist to assess the presence of depression 
(Bowling, 2005; McAlpine & Wilson, 2004), it often remains  undetected within 
primary care (Gilbody et al, 2003; McAlpine & Wilson, 2004; Paykel & Priest, 
1992). In order to improve referral and treatment of depression, the 
occurrence of accurate diagnosis needs to be increased. However, large-
scale solutions to this may be problematic. The US Preventative Services 
Task Force (USPSTF), for example, have recommended the use of routine 
screening programs for depression in clinical practices in order to improve 
diagnosis of depression (2002). While clinical criticism of the use of screening 
methods tends to go against the accepted opinion of the medical 
establishment (Palmer & Coyne, 2003), screening all patients for depression, 
regardless of whether they are showing symptoms raises serious ethical 
concerns regarding patient rights, obligations, enforcement and social justice. 
This is particularly important as it has been suggested that such a screening 
program may have a minimal impact on detection rates (although it may pick 
up the less severe cases that are generally missed by practitioners) (McAlpine 
& Wilson, 2004). Issues surrounding screening are made more acute with 
growing interest in genetic screening for pre-disposition to depression. Is 
there a future where people are genetically labelled from birth as being at risk 
of depression, thus subjecting them to discrimination and social inequality 
from birth or youth? The answer to this question lies in who collects this 
information; who has ownership of and rights to it and where it is stored. If 
insurance companies and potential employers, for example, can buy the 
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results of population-level testing or even demand individual genetic or 
psychological screening for all applicants, this raises serious ethical concerns. 
 
Screening programs are often promoted as being for the good of the 
depressed by increasing detection rates. While there is probably a legitimate 
argument that diagnosis aids treatment, it is not as clear cut as this. There is 
clearly an alternative discourse in which corporate agendas (i.e. profit) clash 
with the rights of the individual to manage their own symptoms, and the way 
that they are presented within the world. 
 
In the public and professional discourse surrounding screening programs 
there is also a need to acknowledge and disseminate the pluses and minuses 
of different screening procedures and treatments in order to avoid the kind of 
informational paternalism discussed in the introduction. Acknowledging the 
social stigma attached to depression and its consequences, means that public 
interventions, such as mass screening programs, have to be seen in a social 
as well as a clinical light. At the patient level, diagnosis also needs to be 
supported by good and appropriate treatment  which is not always the case 
(Gilbody et al, 2003; McAlpine & Wilson, 2004; USPSTF, 2002). Perhaps 
treatments should always include preparation for dealing with the stigma and 
discrimination attached to sufferers both by the rest of the world and by 
themselves, with the stigmatising effects of depression necessarily being dealt 
with at the practitioner and patient level as well as the public one.    
 
While long-term social and legal efforts must be made to reduce stigma and 
address discrimination suffered by those with depression, these issues still 
affect the lives of sufferers. Greater sensitivity to this must illuminate 
discussions and practice of diagnosis, intervention and treatment. Sufferers 
from depression experience social injustice resulting from their clinical 
diagnosis, therefore, any discussion of large-scale interventions must 
consider this. Equity of population-scale interventions against depression 
does not just concern equality of clinical outcome but also social justice for the 
depressed.  
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A discussion of some particular population-level interventions  
 
Web-based psychological interventions 
 
A number of groups are currently developing ways of delivering cognitive 
behavioural therapy (CBT) interventions against depression automatically via 
a web-site (Christensen et al 2002 & 2004; Clarke et al 2002 & 2005; Patten, 
2003). CBT is itself a well validated therapy for depression (Elkin et al, 1989; 
Scott, 1996; De Rubeis et al 1999; Huibers et al, 2003), but if it can be 
delivered in an effective manner without involving a human therapist, it can be 
used as part of interventions at the population level. One possibility would be 
a health promotion campaign encouraging persons who feel depressed to go 
to a screening web-site and then directing those who have scores indicating 
depression to the CBT site. Current evidence seems to indicate that web-
based CBT is effective against mild depression, but it has as yet not been 
used in a population-level intervention. 
 
A web-assisted health promotion campaign would to some degree circumvent 
worries about stigmatisation, because the users of the screening and the 
treatment would not be identifiable. It would, however, raise issues of justice 
since the users would be unlikely to be a cross-section of the population. 
Internet access is not evenly distributed across society, and the propensity to 
use a cognitive therapy like CBT might also differ according to educational 
attainment. A web-assisted health promotion campaign would thus have to be 
only a part of a larger health promotion intervention if the aim was to reach the 
whole population at risk. 
 
An issue for any program involving web-based screening or other forms of 
self-screening by potential patients is the quality of the screening tools, and 
whether they are validated for this specific kind of use. Given the issue of 
stigma discussed above it is very important that the screening tool does not 
have a high false positive rate. One of the scales commonly used is the self-
rated Goldberg Depression Scale. This scale has been validated in general 
practice populations, but never for population screening, and never for 
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internet use in particular, and it has furthermore, like most rating scales only 
been validated in a few countries and languages (Holm et al, 2001). We 
therefore do not know what the false positive rate for this scale is when used 
at the population level, and this is also the case for all the other rating scales 
currently used on the internet. 
 
Over the counter sale of anti-depressants as an intervention strategy 
 
Allowing over the counter (OTC) sales of (some) anti-depressants is a 
possible population intervention strategy directed towards the milder end of 
the depression spectrum. Newer anti-depressants have less side-effects, are 
less toxic, and have less potential as suicide agents than the older ones; and 
it is therefore at least in theory possible to allow people who diagnose 
themselves as suffering from depression to buy these drugs without 
prescription. There are plenty of validated depression screening tests 
available on the internet (as discussed above) and in popular books, so it 
would be possible for people to screen themselves before buying the drugs. 
 
The main positive feature of this strategy is that it reduces the risk of 
stigmatisation. The person does not have to seek professional help to get 
access to effective treatment, and he or she will not be registered anywhere 
as a buyer of anti-depressants as they would be if the drugs where bought on 
prescription. 
 
There are, however, also significant problems. The first problem is a problem 
with the evidence: we do not know whether and how well the strategy will 
work, since it has not been trialled or evaluated (including issues surrounding 
self-screening). The second cluster of problems are all concerned with 
whether we, as a society want to extend the use of anti-depressants. Would 
people who were not depressed but just sad start taking the drugs, or would 
non-depressed and non-sad people take them to become happier? There is 
an extensive literature on whether it is problematic that the new anti-
depressants are used by healthy people as so-called “life style drugs”, and an 
even more extensive literature on whether there is anything wrong in principle 
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with healthy people enhancing themselves through pharmaceutical means. 
The basic point of controversy is whether there is anything special about 
pharmaceutical enhancement that makes is more problematic than other 
kinds of enhancement. Most people try to enhance themselves in various 
ways, for example by reading academic books, and we do not normally find 
that wrong. A possible difference in the psychiatric area is that enhancement 
obscures the “authentic self”: if I make myself happier and more carefree with 
SSRIs I am no longer myself. The strength of this argument is, however, 
disputed, partly because it is very difficult to define with any precision what a 
person’s authentic self is (as evidenced in the common comment that “it is 
only when he is drunk that you realise how nasty he really is”). 
 
A final problem for this intervention strategy is that in most countries 
marketing rules for OTC products are more liberal than the marketing rules for 
prescription only products, for instance by allowing direct to consumer 
advertising. Moving anti-depressants into the OTC category might therefore 
allow the pharmaceutical industry to induce demand for these drugs through 
advertising (Spurgeon, 1999; Consumer Association, 2001; Evans et al, 2002; 
Mintzes et al, 2002; Holmer, 2002; Colin-Thomes, 2004; Evans, 2004; 
Coulter, 2004). 
 
School-based interventions and interventions in the young  
 
Childhood depression has become a major health issue (Merry et al, 2005; 
Sanci et al, 2000) with increasing numbers of children being treated for it 
(Timimi, 2004; Ramchandani, 2004). The association of childhood depression 
with “poor academic performance, social dysfunction, substance abuse and 
attempted and contemplated suicide” (Merry et al, 2005: 2), with even mild 
depression having a detrimental effect, explains the increased interest in 
preventative interventions over the past decade (Merry et al, 2005). Risk of 
depression increases throughout adolescence (Ramchandani, 2004) making 
the need for prevention seem even more acute.    
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Such preventative measures raise ethical concerns. A preventative program 
necessitates some element of screening for predisposition to depression. 
However,   symptoms of depression are common in childhood, often 
disappearing without clinical intervention (Ramchandani, 2004). Evidence for 
the effectiveness of preventative interventions in youth is still limited 
(Beardslee et al, 2003; Merry et al, 2005; Spence et al, 2003) as is evidence 
for the benefits of routine screening of youth for depression (USPSTF, 2002), 
with a Cochrane Review recommending that the implementation of 
preventative programs is premature (Merry et al, 2005). It has, for example, 
been argued that increasing reporting of adolescent depression may be the 
result of changing concepts of childhood including an over-medicalising of 
childhood emotion and that the symptoms of the children diagnosed as 
depressed do not reflect adult symptoms as is often claimed (Timimi, 2004). 
Potential failings in diagnosing childhood depression have severe implications 
for the application of any subsequent intervention, particularly in preventative 
programs involving mass screening: the unnecessary labelling of a young 
person as depressed may be highly problematic for that child. At particularly 
vulnerable times during development, they may be tagged with an identity 
which affects the way that they both see and present themselves, and the way 
in which the world will see them. This could have negative repercussions 
throughout their lives. Having already identified the social stigma still attached 
to such labels, it is worth emphasising that the social environment of school 
students is very effective at labelling and discriminating against anyone 
perceived as deviant from normalised behaviour or character. Any pupil 
labelled as depressed by either themselves, their peers or adults will have to 
negotiate this identity within the school environment.      
  
Clearly, there are both social and financial cost implications associated with 
large-scale primary prevention interventions. It would seem impossible to 
target such interventions effectively and fairly. While it has been shown, for 
example, that children whose parents are depressive are prone to developing 
psychiatric disorders themselves (Beardslee et al, 2003;  Timimi, 2004), it is 
impossible to disentangle environmental and biological determinants of child 
depression (Timimi, 2004). This suggests that the accurate identification of 
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adolescents pre-disposed to depression is unachievable, meaning that 
preventive programs would need to remain broad and untargeted. Accepting 
all the above evidence, it would seem necessary for the development of any 
large-scale preventive program for adolescents to consider the risks of the 
program to the adolescents it is seeking to help. In the absence of better 
evidence for broad interventions, it would seem wise to focus on secondary 
interventions for depression in the young. However, these should be 
undertaken in the light of more research into and debate around what 
adolescent depression is, and what adolescent depression is not, as these will 
influence methods of treatment. If adolescent depression is different to adult 
depression, then perhaps it requires different treatments. Certainly, there are 
questions, for example, around the increasing use of antidepressants with 
children (Jureidini et al, 2004). If adolescent depression is no different to adult 
depression and is even a precursor to likely adult depression (Fombonne et 
al, 2001) then this has implications for lifelong treatment of depression, and 
would seem to advocate early detection and intervention. 
 
While these debates are important reflections of understandings of depression 
and the treatment of it, through all these discussions the young sufferer of 
depression (however they are labelled) must not be forgotten and it is crucial 
that they find support from those around them. Clear information targeted at 
both adolescents themselves and those that care for them, such as some of 
that to emerge from the Defeat Depression Campaign (Graham & Hughes, 
1995; Royal College of Psychiatrists, 2005), is crucial in maintaining this 
support. As stigmatising attitudes appear to form early, there is also scope for 
educational campaigns within schools to reduce this stigma (Crisp et al, 
2000). 
 
Whether preventative or curative, it is a fair assumption that interventions into 
depression among the young are likely to be located in schools, raising 
several ethical issues. Schools are often identified as appropriate sites for 
many types of health promotion (Evans-Whipp et al, 2004; Lynagh et al, 1997; 
Nutbeam & Aaro, 1991). Consequently, schools can feel over-burdened with 
responsibility for researching and promoting health at the expense of what is 
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seen as their primary function, education (St Leger & Nutbeam, 2000; Samdal 
et al, 1998). Any school-based depression intervention must respect this, 
minimising disruption to teaching while benefiting the school and its students. 
If an intervention  program is of uncertain benefit then it is unethical to use up 
both school and pupil  time on this. An exception to this might be during the 
trialling of an intervention.      
 
If a school-based intervention is adopted, other ethical issues are raised. It is 
easy to say that any intervention should be conducted in such a way, and in 
such a location as to allow the confidentiality of pupil participants. But to what 
extent is this actually the case? If during screening a pupil is diagnosed as 
depressed, who has the right or need to know this, and who controls this 
information? Certainly, it is easy to argue for a pupil’s right that their peers are 
not informed: they do not operate on behalf of the student and therefore have 
no need to know. However, parents, schools and health professionals all act 
on behalf of minors, so who should be informed of the diagnosis, and who 
should give consent to treatment? Answers to these questions may also be 
affected by the age of the child, and national legal understandings of the age 
at which they can make autonomous decisions. This is particularly pertinent if 
the student has sought out counselling on the school site for themselves. 
 
However, if the child is not judged to be old enough to make these decisions, 
and often even if they are, rights and responsibilities post diagnosis often 
need to be resolved between school and parent, ideally in an agreed 
partnership.   Who has the right to know this information and make decisions 
about the child; who has the need to know this information and make 
decisions about the child and is there a difference between a right and a 
need? Parents, staff and pupils may view these rights and needs very 
differently, and there are important questions as to why access to information 
and decision making may be necessary or desired. A school may argue, for 
example, that they need this information to facilitate the child’s education. 
Parents may argue that they do not want the school to know in order to avoid 
the stigmatisation of their child. The child themselves might feel that they are 
the only one who has the right to know. While alternative sites (e.g. youth 
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clubs, clinics) may be seen as a solution to the problem of school-based 
interventions, many similar ethical issues would be raised with any 
intervention based around the treatment of minors. Interest in addressing 
youth depression can be seen as another expression of the tendency for 
health policy to try to achieve long-term population health gains by targeting 
youth health in order to establish lifelong patterns of healthy behaviour. 
However, due to the stigma associated with depression; uncertainty around 
diagnosis and treatment of depression in the young; and the legal status of 
minors, depression screening and interventions in the young, particularly 
when school-based, raises many ethical issues that should be considered by 
those involved with them.   
 
Environmental interventions 
 
Environmental interventions appear to suggest vast possibilities in addressing 
depression. Environment is a term that is constructed to mean many things. 
For example writing on mental health and the environment includes work on 
symbolic meaning and therapeutic landscapes (Wilson, 2003); geographies of 
the mentally ill within cities (Gleeson et al, 1998), and the spatial experiences 
of those suffering from mental illness (Segrott & Doel, 2004). Such insights 
into the lived experience of mental health could lead to innovative 
interventions to help address psychiatric disorders including depression. 
However, the literature on environment and health tends to be mainly located 
within planning and is dominated by the theme of the built environment and 
the impacts of urbanisation on health. However, this appears most often to 
consider physical health. Where mental health is considered it is more often 
as a generic term rather than with reference to specific conditions such as 
depression. This would appear to suggest that planning interventions may not 
be particularly sensitive to mental health issues despite their importance as 
interventions in the relationship between environment and health. Similarly, 
while Health Impact Assessment is increasingly undertaken alongside 
environmental and planning policy (Kemm & Parry, 2004), it seems to lack an 
explicit focus on mental health.  
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Interestingly, of all psychiatric disorders, depression is the most commonly 
singled out for attention by the planning literature. The reason for this appears 
to be at the heart of a very important matter. Somewhere in some broader 
social consciousness, depression, in its broad and lay meaning, is often 
associated with the cities. Crucially, this fixation with health and the urban 
would appear to echo the popular urban-rural dualism in which the urban 
(unhealthy) is dichotomised with the rural (healthy). Such a notion of the rural 
idyll has long been challenged within changing understandings of rural areas 
(Cloke et al, 1994; Hoggart, 1990). This concentration on health and the 
urban evokes images of the preoccupation with cities as miasma-laden places 
of contagion and disease in the late 1800s (Halliday, 2001; Susser & Susser, 
1996). If these ideas still persist, consciously or sub-consciously within 
planning, then these dominant interventions may overlook mental health 
problems in rural areas, despite a body of literature demonstrating the needs 
of these areas (Philo et al, 2003). Consideration of any planning intervention 
to improve mental health needs to ask to what extent the intervention is based 
upon evidence, and to what extent is it drawing upon folklore and myth. 
Where primarily the latter is involved, it would be hard to justify the expense of 
such costly and sweeping interventions.    
 
Areal variation in health has been observed for more than a century (Ellaway 
et al, 2001), and links between human health and the built environment are 
increasingly recognised (Jackson, 2003). For example, evidence indicates an 
association between poor housing conditions and poor health, including 
incidence of depression (Blackman et al, 2001). Before conducting any 
environmental intervention though, it is important to understand the reason for 
these trends. For example, are these differences due to character of the area 
itself (contextual), or the characteristics of the people who live there 
(compositional) (Ellaway et al, 2001)? Or perhaps it is due to an interplay of 
both of these. If the fabric of the area is causing depression, then 
interventions to change the physical landscape and architecture might be 
appropriate. However, if the people living in an area are more prone to 
depression, successful interventions must understand why this may be the 
case. This may be due to perceptions of the local environment (Ellaway et al, 
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2001) (suggesting an interplay between physical environment and people); the 
socio-economic status of the area (a key determinant of health) or the role of 
social capital at both the individual and community levels (Ellaway et al, 2001; 
Ziersch et al, 2005).  
 
If risk of depression is linked to a person’s environment, then this suggests 
that there is inequality in our physical landscape. Whatever the nature of this 
association, again  depression can be seen to be a social justice issue. 
Improvement of environmental interventions can occur by broadening 
understandings of the relationship between health and the environment. Not 
only should more planning draw on a wider literature to increase its 
effectiveness in reducing depression, but the profile of alternative 
environmental interventions, drawing on different understandings of the 
relationship between depression and the environment, should be raised.  
 
Conclusion 
 
To reiterate, this paper represents the English-language publication of a 
chapter translated into German for a book written in response to the perceived 
increase in the prevalence of depression. With this rise has come an increase 
in attempts to address it and this chapter, part of a section on interventions, 
discusses the ethical context of large-scale (population-level) interventions to 
address depression. In this chapter we have tried to show that many types of 
large-scale interventions against depression are not ethically unproblematic. 
There is a significant difference between treating people who seek help, and 
searching for people whom we think need help. This difference is especially 
important in contexts where acquiring a certain kind of diagnostic label has 
significant negative implications for the person in question. As our discussion 
of stigma has shown, getting a psychiatric label is often more stigmatising 
than getting some other diagnostic label. If the mere fact that I have been 
labelled as “at risk for developing depression” affects my life negatively, then it 
becomes important that we do not implement interventions that use screening 
tools with low diagnostic accuracy. While the problem of stigmatisation does 
not affect population-level intervention strategies that aim to reduce the 
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incidence of depression through a general change in the physical or 
psychological environment, such interventions are not (yet?) supported by the 
same kind of evidence as more individualised strategies are. Consequently, in 
the current climate or prevailing attitudes towards mental health generally, 
and depression in particular, the use of population-level interventions raises 
serious ethical considerations that cannot be ignored.  
Working Paper no.5, CISHE, School of Social Sciences, Cardiff University 
May 2006 20
References 
 
Beardslee, W.R., Gladstone, T. R.G., Wright, E.J. & Cooper, A.B. (2003) ‘A 
family-based approach to the prevention of depressive symptoms in children 
at risk: evidence of parental and child change’ in Pediatrics, 112,2 (online 
article) p.e119-e131  
 
Blackman, T., Harvey, J., Lawrence, M. & Simon, A. (2001) ‘Neighbourhood 
renewal and health: evidence from a local case study’ in Health and Place, 7, 
pp.93-103 
 
Bloch, S., Chodoff, P. & Green, S. (Eds.) (1999) Psychiatric Ethics. Oxford: 
Oxford University Press. 
 
Bowling, A. (2005) Measuring health, Maidenhead: Open University Press     
 
Christensen. H., Griffiths, K.M.& Korten A. (2002) ‘Web-based Cognitive 
Behavior Therapy: Analysis of Site Usage and Changes in Depression and 
Anxiety Scores’ in Journal of  Medical Internet Research 4,1, p. e3 
 
Christensen, H., Griffiths, K.M., Korten, A., Brittliffe, K.& Groves, C. (2004) ‘A 
Comparison of Changes in Anxiety and Depression Symptoms of 
Spontaneous Users and Trial Participants of a Cognitive Behavior Therapy 
Website’ in Journal of Medical Internet Research, 6,4, p. e46 
 
Clarke, G., Reid, E., Eubanks, D., O'Connor, E., DeBar, L.L., Kelleher, C., 
Lynch, F. & Nunley, S. ‘Overcoming Depression on the Internet (ODIN): A 
Randomized Controlled Trial of an Internet Depression Skills Intervention 
Program’ in Journal of Medical Internet Research 4,3, p. e14 
 
Clarke, G., Eubanks, D., Reid, E., Kelleher, C., O’Connor, E., DeBar, L.L., 
Lynch, F., Nunley, S. & Gullion, C. (2005). ‘Overcoming Depression on the 
Internet (ODIN) (2): A Randomized Trial of a Self-Help Depression Skills 
Program With Reminders’ in Journal of Medical Internet Research 7,2, p. e16 
Working Paper no.5, CISHE, School of Social Sciences, Cardiff University 
May 2006 21
 
Cloke, P., Doel, M., Matless, D., Phillips, M. & Thrift, N. (1994) Writing the 
rural: five cultural geographies London: Paul Chapman Publishing  
 
Colin-Thome, D. (2004) ‘Empowering patients through access to information’, 
in Asato, J. (Ed) Direct to patient communication: patient empowerment or 
NHS burden? London: Social Market Foundation, pp. 10-15 
 
Consumer Association (2001) Promotion of prescription drugs: public health 
or private profit? London: Consumers’ Association 
 
Coulter, A. (2004) ‘Why the ban on direct-to-consumer advertising of 
prescription medicine should remain in place’, in Asato, J. (Ed.) Direct to 
patient communication: patient empowerment or NHS burden? London: Social 
Market Foundation, pp. 37-43 
 
Crisp, A.H., Gelder, M.G., Rix, S., Meltzer, H.I. & Rowlands, O.J. (2000) 
‘Stigmatisation of people with mental illness’ in The British Journal of 
Psychiatry, 177,1 pp.4-7 
 
DeRubeis, R.J, Gelfand, L.A., Tang, T.Z. & Simons, A.D.(1999) ‘Medications 
versus cognitive behavior therapy for severely depressed outpatients: Meta-
analysis of four randomized comparisons´ in American Journal of 
Psychiatry,156,7 pp.1007–1013.  
 
Elkin, I., Shea, M.T., Watkins, J.T., Imber, S.D., Sotsky, S.M., Collins, J.F., 
Glass, D.R., Pilkonis, P.A., Leber, W.R., Docherty, J.P, et al. (1989) ‘National 
Institute of Mental Health Treatment of Depression Collaborative Research 
Program. General effectiveness of treatments’ in Archives of General 
Psychiatry, 46,11 pp.971–982. 
 
Ellaway, A., Macintyre, S. & Kearns, A. (2001) ‘Perceptions of place and 
health in socially contrasting neighbourhoods’ in Urban Studies, 12 pp.2299-
2316 
Working Paper no.5, CISHE, School of Social Sciences, Cardiff University 
May 2006 22
 
Evans, T. (2004) The state, the market and freedom of health information, In 
Asato, J. (Ed.) Direct to patient communication: patient empowerment or NHS 
burden? London: Social Market Foundation, p. 32-36 
 
Evans-Whipp, T.; Beyers, J.M.; Lloyd, S.; Lafazia, A.N.; Toumbourou, J.W.; 
Arthur, M.W. & Catalano, R.F. (2004) ‘A review of school drug policies and 
their impact on youth substance use’ in Health Promotion International, 19,2 
pp.227-234 
 
Fombonne, E., Wostear, G., Cooper, V., Harrington, R. & Rutter, M. (2001) 
‘The Maudsley long-term follow-up of child adolescent depression’ in British 
Journal of Psychiatry, 179 pp.210-217 
 
Gilbody, S.M., Whitty, P.M., Grimshaw, J.M. & Thomas, R.E. (2003) 
‘Improving the detection and management of depression in primary care’ in 
Quality and Safety in Health Care, 12 pp.149-155 
 
Gleeson, B., Hay, C. & Law, R. (1998) ‘The geography of mental health in 
Denedin, New Zealand’ in Health & Place, 4,1 pp.1-14    
 
Glozier, N. (1998) ‘Workplace effects on the stigmatization of depression’ in 
Journal of Occupational and Environmental Medicine, 40,9 pp.793-800   
 
Gordon, D. (1994) Personality disorder – who needs protecting BMJ, 308, 
p.420   
 
Graham, P & Hughes, C. (1995) So young, so sad, so listen, London: Gaskell/ 
West London Health Promotion Agency  
 
Halliday, S. (2001) ‘Death and miasma in Victorian London: an obstinate 
belief’ in British Medical Journal, 323, pp.1469-1471 
 
Working Paper no.5, CISHE, School of Social Sciences, Cardiff University 
May 2006 23
Halter, M.J. (2004) ‘The stigma of seeking care and depression’ in Archives of 
Psychiatric Nursing 18, 5, pp.178-184 
 
Hirsch, S.R. & Harris J. (Eds.) (1988) Consent and the Incompetent Patient: 
Ethics, Law, and Medicine. London: Gaskell & The Royal College of 
Psychiatrists. 
 
Hoggart, K. (1990) ‘Let’s do away with rural’ in Journal of Rural Studies, 6, 3 
pp.245-257 
 
Holm, J., Holm, L. & Bech, P. (2001) ‘Monitoring improvement using a patient-
rated depression scale during treatment with anti-depressants in general 
practice. A validation study on the Goldberg Depression Scale’ in 
Scandinavian Journal of Primary Health Care 19, 4 pp. 263-266 
 
Holm, S. & Burgess, S. (2006) ‘Interventionen und ethischer Kontext’ in 
Stoppe, G., Bramesfeld, A. & Schwartz, F.W. (eds) Volkskrankheit 
Depression? Bestandsaufnahme und Perspektiven Springer Medizin Verlag: 
Heidelberg 
 
Holmer, A.F. (2002) ‘Direct-to-consumer advertising – strengthening our 
health care system’ in New England Journal of Medicine, 346 pp. 526-528 
 
Huibers, M.J.H., Beurskens, A.J.H.M., Bleijenberg, G. & van Schayck CP 
(2003) ‘The effectiveness of psychosocial interventions delivered by general 
practitioners’ in The Cochrane Database of Systematic Reviews, 2003,2 art 
no. CD003494 
 
Jackson, L.E. (2003) ‘The relationship of urban design to human health and 
condition’ in Landscape and Urban Planning, 64 pp.191-200  
 
Jorm, A.F. (2000) ‘Mental health literacy’ in The British Journal of Psychiatry, 
177, 5 pp.396-401 
 
Working Paper no.5, CISHE, School of Social Sciences, Cardiff University 
May 2006 24
Jureidini, J.N., Doecke, C.J., Mansfield, P.R., Haby, M.M., Menkes, D.B. & 
Tonkin, A.L. (2004) ‘Efficacy and safety of antidepressants for children and 
adolescents’ in British Medical Journal, 328 pp.879-883 
 
Kemm, J. & Parry, J. (2004) ‘What is HIA? Introduction and overview’ in 
Kemm, J., Parry, J. & Palmer, S. (Eds) Health impact assessment, Oxford: 
Oxford University Press  
 
Lynagh, M.; Schofield, M.J. & Sanson-Fisher, R.W. (1997) ‘School health 
promotion programs over the past decade: a review of the smoking, alcohol 
and solar protection literature’ in Health Promotion International, 12,1 pp.43-
60 
 
McAlpine, D.D. & Wilson, A.R. (2004) ‘Screening for depression in primary 
care: what do we still need to know?’ in Depression and Anxiety, 19 pp.137-
145 
 
Merry, S., McDowell, H., Hetrick, S., Bir, J. & Muller, N. (2005) Psychological 
and/or educational interventions for the prevention of depression in children 
and adolescents (Review) The Cochrane Collaboration: John Wiley and Sons 
 
Mintzes, B., Barer, M.L., Kravitz, RL., Kazanjian, A., Bassett, K. Lexchin, J.,  
Evans, R.G., Pan, R. & Marion S.A. (2002) ‘Influence of direct to consumer 
pharmaceutical advertising and patients' requests on prescribing decisions: 
two site cross sectional survey in British Medical Journal, 324 pp. 278 - 279 
 
Nutbeam, D. & Aaro, L.E. (1991) ‘Smoking and pupil attitudes towards school: 
the implications for health education with young people’ in Health Education 
Research, 6,4 pp.415-421  
 
Palmer, S.C. & Coyne, J.C. (2003) ‘Screening for depression in medical care 
pitfalls, alternatives and revised priorities’ in Journal of Psychosomatic 
Research, 54 pp.279-287   
 
Working Paper no.5, CISHE, School of Social Sciences, Cardiff University 
May 2006 25
Patten, S.B. ‘Prevention of depressive symptoms through the use of distance 
technologies’ in Psychiatric Services 54,3 pp. 396-398 
 
Paykel, E.S. & Priest, R.G. (1992) ‘Recognition and management of 
depression in general practice: consensus statement” in British Medical 
Journal, 305,6863 pp.1198-1202 
 
Paykel, E.S., Hart, D. & Priest, R.G. (1998) ‘Changes in public attitudes to 
depression during the Defeat Depression Campaign’ in British Journal of 
Psychiatry. 173,6 p.519-522   
 
Philo, C., Parr, H. & Burns, N. (2003) ‘Rural madness: a geographical reading 
and critique of the rural mental health literature’ in Journal of rural Studies, 19 
pp.259-281    
 
Ramchandani, P. (2004) ‘Treatment of major depressive disorder in children 
and adolescents’ in British Medical Journal, 328, pp.3-4 
 
Royal College of Psychiatrists (2005) About Defeat Depression, available on-
line at http://www.rcpsych.ac.uk/campaigns/defeat/  (last accessed 13th June 
2005) 
 
St Leger, L. & Nutbeam, D. (2000) ‘Research into health promoting schools’ in 
Journal of School Health, 70,6 pp.257-259 
 
Samdal, O.; Nutbeam, D.; Wold, B. & Kannas, L. (1998) ‘Achieving health and 
educational goals through schools – a study of the importance of the school 
climate and the students’ satisfaction with school’ in Health Education 
Research, 13,3 pp.383-397 
 
Sanci, L.A., Coffey, C.M.M., Veit, F.C.M., Carr-Gregg, M.C., Patton, G.C., 
Day, N. & Bowes, G. (2000) ‘Evaluation of the effectiveness of an educational 
intervention for general practitioners in adolescent health care: randomised 
control trial’ in British Medical Journal, 320, pp.224-230 
Working Paper no.5, CISHE, School of Social Sciences, Cardiff University 
May 2006 26
 
Scott, J. (1996) ‘Cognitive therapy of affective disorders: A review’ in Journal 
of Affective Disorders, 37,1 pp. 1–11  
 
Segrott, J. & Doel, M.A. (2004) ‘Disturbing geography: obsessive-compulsive 
disorder as spatial practice’ in Social & Cultural Geography, 5, 4 pp.597-613   
 
Spence, S.H., Sheffield, J.K. & Donovan, C.L. (2003) ‘Preventing adolescent 
depression: and evaluation of the problem solving for life program’ in Journal 
of Consulting and Clinical Psychology, 71, 1 pp.3-13 
 
Spurgeon, D. (1999) ‘Doctors feel pressurised by direct to consumer 
advertising’ in British Medical Journal, 319 p. 1321 
 
Susser, M. & Susser, E. (1996) ‘Choosing a future for epidemiology: I. eras 
and paradigms’ in American Journal of Public Health, 86, 5 pp.668-673   
 
Timimi, S. (2004) ‘Rethinking childhood depression’ in British Medical Journal, 
329 pp.1394-1397 
 
U.S. Preventative Services Task Force (2002) ‘Screening for depression: 
recommendations and rationale’ in Annals of Internal Medicine, 136, 10 
pp.760-764  
 
Wilson, K. (2003) ‘Therapeutic landscapes and First Nations peoples: an 
exploration of culture, health and place’ in Health and Place, 9 pp.83-93   
 
World Health Organization (2004) Prevention of Mental Disorders: Effective 
Interventions and Policy Options: Summary Report, Geneva: WHO available 
online: 
http://www.who.int/mental_health/evidence/en/prevention_of_mental_disorder
s_sr.pdf 
 
Working Paper no.5, CISHE, School of Social Sciences, Cardiff University 
May 2006 27
Ziersch, A.M., Baum, F.E., MacDougall, C. & Putland, C. (2005) 
‘Neighbourhood life and social capital: the implications for health’ in Social 
Science and Medicine, 60 pp.71-86     
 
 
